My summary & take on today's Investor Briefing ...
- slide deck & talking points were the same content as last weeks MST session. No new info, to be expected, as there's been no new ps Ann's
BUT.... and this is why I like attending these events in person, the additional insight gained from chatting to fellow SHrs, listening to their viewpoints & Qs, watching the body language of, and conversing with Pete & Daniel is gold imo
my observations, no particular order...
- Pete (Dr P for short now) is impressive both as a speaker & in conversation. Drs T & P are clearly a great team. They visibly spark off each other. Dr Ps industry knowledge & experience nicely complements Dr Ts unusual combination of CEO capability & mad scientist brilliance
- the execution of upcoming clinical trials clearly are ofcourse a significant execution risk, esp given the AML/EMD experience. A lot of work is still to be done before the first patient is dosed. they know this.
- the strategy behind including HK & SK in the trials is smart in that perhaps it would facilitate a deal in those regions initially ( a la DXB)
- expect deal action once there is solid cpacs data. but there won't be a deal that is not in SH interests
- there is stuff going on that we don't know about
- if a big investor were to come on board it would prob be to fund something that is not already funded by us already. I'm guessing now but maybe another molecule ? new trials ? ... insert your own speculation here
- judging by the Qs & conversations, there are some very smart fellow SHrs in Perth
- not withstanding the inherent risks in any investment, especially biotechs, I'm feeling good about Races prospects & future.
Hopefully RAC run similar sessions in other cities. if you are able to attend, I strongly recommend as a great investment of your time as much more to be gained than just watching video.
All the above just my opinion, please make up your own mind & seek advice as necessary.
Good luck in your investing !
- Forums
- ASX - By Stock
- Ann: Race In-person Investor Briefing Invitation Perth
My summary & take on today's Investor Briefing ...- slide...
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M |
Open | High | Low | Value | Volume |
$1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 31396 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.440 |
1 | 11250 | 1.390 |
1 | 1000 | 1.380 |
1 | 5000 | 1.370 |
1 | 1279 | 1.365 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 31396 | 1 |
1.480 | 3055 | 2 |
1.500 | 17040 | 2 |
1.520 | 6000 | 1 |
1.575 | 2000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online